Pharmacokinetic behavior of vancomycin in neonates of postconceptional age ≤32 weeks. Recommended dosage guideline;Comportamiento farmacocinetico de la vancomicina en neonatos de edad postconcepciona ≤32 semanas. Propuesta de una pauta de dosificacion

Anales Espanoles de Pediatria

Volumn 45, Issue 2, 1996, Pages 167-171

  Ginovart Galiana, G ^a,b   Mangues Bafalluy, M A ^a   Demestre Guasch, X ^a   Farre Riba R ^a   Lopes Santos, A P ^a   Altirriba Valls, O ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HSCSP   (Spain)

Author keywords

indomethacin; mechanical ventilation; pharmacokinetics; premature neonates; serum creatinine; vancomycin

Indexed keywords

CREATININE; VANCOMYCIN; ANTIINFECTIVE AGENT; INDOMETACIN;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE; DRUG ELIMINATION; DRUG HALF LIFE; GESTATIONAL AGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; PHARMACOKINETICS; PRACTICE GUIDELINE; PREMATURITY; BLOOD; DOSE RESPONSE; METABOLISM; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; RESPIRATION, ARTIFICIAL; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 0029843915     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. St. Geme III JW, Harris MC. Coagulase-negative staphylococcal infection in the neonate. Clin Perinatol 1991;18:281-302.
2. Hall SL. Coagulase-negative staphylococcal infections in neonates. Pediatr Infect Dis J 1991;10:57-67.
3. Peter G, Cashore WJ. Infections acquired in the nursey. Epidemiology and control. En: Remington JS, Klein J (ed). Infections Diseases of the fetus and newborn infant. Philadelphia: WB Saunders Co, 1990;1000-1019.
4. Javis WR Epidemiology of nosocomial infections in pediatric patients. Pediair Infect Dis J 1987;6:344-351
5. Vega González MA, García Gscheidle A, Orejón de Luna G, Velasco JJ, Gómez Castillo E, Medina López MC. Estafilococo coagulasa negativo en recién nacidos. ?Cuándo le damos valor?. An Esp Pediatr 1994;40:344-347.
6. Ginovart Galiana G, Andreu Duat MD, Farré Riba R, Mangues Bafallull A, Demestre Guasch X, Raspall Torrent F, Altirriba Valls O. Sepsis por estafilococo coagulasa negativo en el recién nacido. Aspectos clínicos y terapéuticos. An Esp Pediatr 1993;38:488-492.
7. Freeman J, Epstein MF, Smith NE, Platt R, Sidebottom DG, Goldman DA. Extrahospital stay and antibiotic usage with nosocomial coagulase-negative staphylococci bacteremia in two neonatal intensive care unit populations. Am J Dis Child 1990;144:324-329.
8. Martín MA, Pfaller MA, Wenzel RP. Coagulase negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:9-16.
9. Baumgart S, Hall SE, Campos JM, Polin RA. Sepsis with coagulase-negative staphylococci in critically ill newborns. Am J Dis Child 1983;137:461-463.
10. Hall RT, Hall SL, Barnes WG, Iznegbu J, Rogolsky M, Zorbas I. Characteristics of coagulase-negative staphylococci from infants with bacteremia. Pediatr Infect Dis J 1987;6:377-383.
11. Mangues MA, Farré R, Sala P, Guasch E, Balet A, Longoni M, Raspall F, Demestre X, Bonal J. Updating Dosage Guidelines of Vancomycin in neonates. Poster. The 1990 Annual Meeting of the American College of Clinical Pharmacy. San Francisco (USA), Agosto 1990
12. Arant BR Jr. Developmental patterns of renal functional maduration compared in the human neonate. J Pediatr 1978;92:705-712
13. Spivey JM, Gal P. Vancomycin Pharmacokinetics in Neonates. Am J Dis Child 1986;140:859.
14. Asbury WH, Darsey EH, Rose WB, Murphy JE, Buffington DE, Capers CC. Vancomycin Phramacokinetics in Neonates and infant: a retrospective evaluation Ann Pharmacother 1993;27:490-496.
15. McCraken GH, Nelson JD. Terapéutica antimicrobiana en el recién nacido. Segunda ed. Buenos Aires: Editorial Médica Paramericana, 1984;32-33.
16. Farré R, Jiménez I, Mangues MA, Guasch E, Ginovart G, Gallastegui C, Rectoret G, Sagrera X, Angomas L, Queraltó JM, Raspall F, Castro I. Vancomycin dosage guidelines in neonates based on pharmacokinetic behaviour. Comunication. Third anual meeting of the Clinical Pharmacokinetics Society: TDM services into the 1990's. London, June 1989.
17. Farré R, Jiménez I, Mangues MA, Guasch E, Ginovart G, Gallastegui C, Rectoret G, Sagrera X, Angomas L, Arcelus R, Queraltó JM, Raspall F, Castro I. Vancomycin pharmacokinetics in neonates. New dosage guidelines recommendations. Comunication. International workshop on clinical pharmacy. Epidemiology of antibiotic drug use. Israel, June 1989.
18. Karlowicz MG, Adelrnan RD Insuficiencia renal aguda en recién nacidos. Clin Perinatol 1992;1:141-161.
19. James A, Koren G, Milliken J, Soldin S, Prober C. Vancomycin pharmacokinetics and dose recommendations for preterm infants. Anti-microb Agents Chemother 1987;31:52-54.
20. Kildoo CW, Lin L-M, Gabriel MH, Folli HL. Vancomycin Pharmacokinetics in Infants: Relationship to Postconceptional Age and Serum Creatinine. Dev Pharmacol Ther 1990;14:77-83.
21. Cifuentes RF, Olley PM, Balfe JW, Raddle IC, Soldin SJ. Indomcthacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979;95:583-587.
22. Murdaugh HV, Seiker HO, Manfredi F. Effects of altered intrathoracic pressure on renal hemodynamics, electrolyte excretion and water clearance. J Clin Invest 1959;38:834-842.
23. Annat G, Viale JP, Xuan BE. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins, urinary ADH and prostaglandins. Anaesthesiology 1983;58:136-141.
24. Moore ES, Gálvez MB, Paton JB, Fisher DE, Behrman RE. Effects of positive pressure ventilation on intrarrenal blood flow in infant primates. Pediatr Res 1974;8:792-796.